Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Broderick, Michael P ^a   Hansen, Christian J ^a   Russell, Kevin L ^a,b   Kaplan, Edward L ^c   Blumer, Jeffrey L ^d,e   Faix, Dennis J ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BODY SURFACE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; GROUP A STREPTOCOCCAL INFECTION; HIGH RISK POPULATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PROTECTION; PUBLIC HEALTH; RECOMMENDED DRUG DOSE; SOLDIER; TANDEM MASS SPECTROMETRY; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; BLOOD; CONFIDENCE INTERVAL; DEMOGRAPHY; DOSE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION;

STREPTOCOCCUS SP. 'GROUP A';

ADOLESCENT; ADULT; CONFIDENCE INTERVALS; DEMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; PENICILLIN G; YOUNG ADULT;

EID: 80053473290     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025308     Document Type: Article

References (18)

1. Elias W, Price AH, Merrion HJ, (1951) N-N'dibenzylethylenediamine penicillin: a new repository form of penicillin. Antibiotics and Chemoth 1: 491.
2. Stollerman GH, Rusoff JH, (1952) Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation. J Am Med Assoc 150: 1571-1575.
3. World Health Organization Rheumatic fever and rheumatic heart disease: Report of a WHO Expert Consultation, Geneva, 29 October-1 November 2001 World Health Organization Technical Report Series 923 2004, Geneva.
4. National Heart Foundation of Australia a, Cardiac Society of Australia and New Zealand (2006) Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia- an evidence-based review. RF/RHD Guideline Development Working Group.
5. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, et al. (2009) Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 119: 1541-1551.
6. Kaplan EL, Johnson DR, (2001) Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis. Pediatrics 108: 1180-1186.
7. Currie BJ, Burt T, Kaplan EL, (1994) Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever. Antimicrob Agents Chemother 38: 1203-1204.
8. Bass JW, Longfield JN, Jones RG, Hartmann RM, (1996) Serum levels of penicillin in basic trainees in the U.S. Army who received intramuscular penicillin G benzathine. Clin Infect Dis 22: 727-728.
9. Kaplan EL, Johnson DR, Del Rosario MC, Horn DL, (1999) Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J 18: 1069-1072.
10. Ndiaye AG, Boye CS, Hounkponou E, Gueye FB, Badiane A, (2009) Antimicrobial susceptibility of select respiratory tract pathogens in Dakar, Senegal. J Infect Dev Ctries 3: 660-666.
11. Mosteller RD, (1987) Simplified calculation of body-surface area. N Engl J Med 317: 1098.
12. Kaplan E, Johnson D, (2001) Unexplained Reduced Efficacy of Oral Penicillin V and Intramuscular Benzathine Penicillin G in the Eradication of Group A Streptococci from Children with Acute Pharyngitis. Pediatrics 108: 1180-1186.
13. Zaher SR, Kassem AS, Abou Shleib H, Kholi AE, (1992) Differences in serum penicillin concentrations following intramuscular injection of benzathine pencillin G (BPG) from different manufacturers. Journal of Pharmaceutical Medicine 2: 17-23.
14. Decourt LV, Santos SR, Snitcowsky R, Pileggi F, Tsuzuki H, et al. (1983) [Serum levels of benzathine penicillin G after intramuscular administration] (in Portuguese). Arq Bras Cardiol 40: 3-8.
15. Raghuram TC, Rao UB, (1979) Serum penicillin levels in rheumatic heart disease. A comparative study in relation to nutritional status. Indian Heart J 31: 333-336.
16. Wright WW, Welch H, Wilner J, Roberts EF, (1959) Body fluid concentrations of penicillin following intramuscular injection of single doses of benzathine penicillin G and/or procaine penicillin G. Antibiotic Med Clin Ther 6: 232-241.
17. Crum NF, Russell KL, Kaplan EL, Wallace MR, Wu J, et al. (2005) Pneumonia outbreak associated with group a Streptococcus species at a military training facility. Clin Infect Dis 40: 511-518.
18. Kaplan EL, Chhatwal GS, Rohde M, (2006) Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Pediatrics 43: 1398-1406.